Pradofloxacin is a new generation of fluoroquinolone antibiotics with broad-spectrum antibacterial activity that exerts its bactericidal effect by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing the replication and repair of bacterial DNA. Pradofloxacin is mainly used for the treatment of bacterial diseases in dogs and cats including skin infections, urinary tract infections and respiratory tract infections.